Short Float History | Indicators | Short Stats | News | Earnings History | Technical Averages | DMPI Yahoo Finance Page

DMPI DelMar Pharmaceuticals Inc.

$1.03 +3%

100,426 Shares Traded
189,830 Average Volume (last 30 days)

as of April 20, 2018 EST IEX Real-Time Price
Click Here to Short Float History Versus Price & Peer Short Floats

Free Newsletter Sign Up

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $54 thousand
If Intiated on the First, Shorts Have Realized a Year to Date Return of:16.26%
If Intiated One Month Ago, Shorts Have Realized a Return of:-5.09%
If Initiated Five Days ago, Shorts Have Realized a Return of:2.83%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points.

Daily Indicators

200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 8.93%
Short Interest1.8 million
Float20.17 million
Short Ratio9.16
Market Cap$22.59 million
Market Maker ActivityDaily Short Volume

News

04-17-2018
DelMar Pharmaceuticals Presents Positive Updates on Two Ongoing Clinical Trials with VAL-083 for Treatment of MGMT-unmethylated GBM (PR Newswire)
04-16-2018
DelMar Pharmaceuticals Announces Multiple Presentations at Annual Meeting of the American Association for Cancer Research (PR Newswire)
02-27-2018
Midday Gainers / Losers (2/27/2018) (SeekingAlpha)
02-20-2018
DelMar Pharmaceuticals' (DMPI) Management on Q2 2018 Results - Earnings Call Transcript (SeekingAlpha)
02-15-2018
Midday Gainers / Losers (2/15/2018) (SeekingAlpha)
02-14-2018
DelMar Pharmaceuticals beats by $0.01 (SeekingAlpha)
02-14-2018
DelMar Pharmaceuticals Announces Second Quarter Fiscal Year 2018 Financial Results (PR Newswire)
12-28-2017
Your Daily Pharma Scoop: Portola BLA Review Process Delayed, DelMar Soars, Alexion Gets Nod For Soliris In Japan (SeekingAlpha)
12-26-2017
DelMar Pharmaceuticals announces Fast Track designation for VAL-083 in recurrent Glioblastoma (SeekingAlpha)
12-26-2017
DelMar Pharmaceuticals Announces Fast Track Designation for VAL-083 in Recurrent Glioblastoma (PR Newswire)


Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 12.7%

Earnings Stats

PE Ratio -1.49
Dividend Yield 0%
Peer EarningsEarnings Calendar

Earnings History For DMPI

Earnings DateQuarterConsensus EPSActual EPSEPS Surprise
2017-11-09 Q1 2018-0.17 (1 Estimates) -0.18-0.01
2017-09-27 AMCQ4 2017-0.19 (2 Estimates) -0.2-0.01
2017-05-12 Q3 2017-0.18 (2 Estimates) -0.18
2017-02-10 Q2 2017-0.17 (2 Estimates) -0.130.04

Technicals

200 Day Moving Average $1.21
50 Day Moving Average $1.07
52 Week High $2.85
52 Week Low $0.78

Back to the Top

Data provided for free by IEX. Questions? Read the FAQ